The inside track on AACR, from Dr Christina Coughlin, Head of R&D, Avacta
Dr Christina Coughlin, Head of R&D at UK targeted oncology developer Avacta, an experienced biotechnology executive and oncologist, is attending the American Association of Cancer Research Annual Meeting, in San Diego. She talked to us about the congress, why it matters to people in cancer research and development, and what the buzz is this year.
LinkRising above the noise, by Suki Virji, PhD, Senior Associate Partner
ICR Consilium regularly attends BioEquity and this year is proud to be a supporting company of the meeting, which is hosted by BioCentury Inc. and EBD Group.
LinkRare Disease Day 2024
Every day we are proud to be working with innovators leading the way in developing therapies to treat rare diseases. 29 February, the rarest day of the calendar, is Rare Disease Day and members of our team are highlighting some of the rare diseases that our clients are focused on.
LinkAMD Awareness Month with Dr Daniel C. Chung
Age-related macular degeneration (AMD) is a disease that can result in severe loss of central vision. February is AMD Awareness Month, so we asked Dr Daniel C. Chung, Chief Medical Officer at SparingVision to explain what the disease is, who is most at risk and its impact on patients.
LinkNot ‘digital healthcare’ – just ‘healthcare’
Senior Associate Partner Chris Welsh and Associate Partner Kris Lam recently attended the Basel Healthtech Conference hosted by MTIP and Stifel, where conversations circled around topics such as the intricacies of data management, enhancing the patient experience in clinical trials and leveraging technology to optimize drug discovery and application.
LinkInternational Day of Women and Girls in Science 2024
At ICR Consilium, we are celebrating all women and girls in science and are proud to be working alongside remarkable women in the industry every day. We asked two female CEOs on what International Day of Women and Girls in Science means to them.
LinkJP Morgan outlook for 2024: sunshine reflects cautious optimism for healthier markets
The annual JP Morgan Healthcare Conference is always a good bellwether for the industry mood music. After a tough 2023, ICR Consilium Partner Tracy Cheung found optimism alive and well in the hotels and conference halls of San Francisco. With several US IPOs in the hopper and plenty of excited discussion about AI and advanced therapies, there’s positivity in the air.
LinkICR Healthcare: What’s in store for ‘24
We asked our colleagues at ICR Healthcare to share their thoughts on what the key themes will be for our industry, what everyone is going to be talking about at the 2024 JP Morgan Healthcare Conference, with a US lens and, most important of all, where to eat in San Francisco.
Link